Addex Therapeutics Ltd - ESG Rating & Company Profile powered by AI
This assessment of Addex Therapeutics Ltd was assembled by All Street Sevva using advanced artificial intelligence. Alternative companies in the rating industry group for Addex Therapeutics Ltd are displayed below. This SDG score for Addex Therapeutics Ltd represents its transparency towards the United Nations SDGs.
Addex Therapeutics Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 8.0, social score of 1.6 and governance score of 8.0.
5.9
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
498 | Redx Pharma PLC | 6.0 | High |
498 | Vimta Labs Ltd | 6.0 | High |
521 | Addex Therapeutics Ltd | 5.9 | High |
521 | Cellink AB | 5.9 | High |
521 | Celon Pharma SA | 5.9 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Addex Therapeutics Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Addex Therapeutics Ltd disclose current and historical energy intensity?
Does Addex Therapeutics Ltd report the average age of the workforce?
Does Addex Therapeutics Ltd reference operational or capital allocation in relation to climate change?
Does Addex Therapeutics Ltd disclose its ethnicity pay gap?
Does Addex Therapeutics Ltd disclose cybersecurity risks?
Does Addex Therapeutics Ltd offer flexible work?
Does Addex Therapeutics Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Addex Therapeutics Ltd disclose the number of employees in R&D functions?
Does Addex Therapeutics Ltd conduct supply chain audits?
Does Addex Therapeutics Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Addex Therapeutics Ltd conduct 360 degree staff reviews?
Does Addex Therapeutics Ltd disclose the individual responsible for D&I?
Does Addex Therapeutics Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Addex Therapeutics Ltd disclose current and / or historical scope 2 emissions?
Does Addex Therapeutics Ltd disclose water use targets?
Does Addex Therapeutics Ltd have careers partnerships with academic institutions?
Did Addex Therapeutics Ltd have a product recall in the last two years?
Does Addex Therapeutics Ltd disclose incidents of discrimination?
Does Addex Therapeutics Ltd allow for Work Councils/Collective Agreements to be formed?
Has Addex Therapeutics Ltd issued a profit warning in the past 24 months?
Does Addex Therapeutics Ltd disclose parental leave metrics?
Does Addex Therapeutics Ltd disclose climate scenario or pathway analysis?
Does Addex Therapeutics Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Addex Therapeutics Ltd disclose the pay ratio of women to men?
Does Addex Therapeutics Ltd support suppliers with sustainability related research and development?
Does Addex Therapeutics Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Addex Therapeutics Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Addex Therapeutics Ltd involved in embryonic stem cell research?
Does Addex Therapeutics Ltd disclose GHG and Air Emissions intensity?
Does Addex Therapeutics Ltd disclose its waste policy?
Does Addex Therapeutics Ltd report according to TCFD requirements?
Does Addex Therapeutics Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Addex Therapeutics Ltd disclose energy use targets?
Does Addex Therapeutics Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Addex Therapeutics Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Addex Therapeutics Ltd
These potential risks are based on the size, segment and geographies of the company.
Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The Charcot"Marie"Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.